Diarylurea-Hydroxyamidine-Based Alzheimer’s Treatment
Tech ID
P27-1321
Patent Status
Granted in India
Design Status
--
Technical Description
This technology presents the multifunctional compounds with dual cholinesterase inhibition, neuroprotection, metal chelation, antioxidant effects, and Aβ aggregation prevention for Alzheimer’s treatment.
Problems Addressed
- Limited Disease Modification
- Ineffective Aβ Aggregation Inhibition
- Weak Metal Chelation Capability
- Inadequate Neuroprotection
- Restricted Cholinesterase Inhibition
- Absence of Multifunctional Agents
TARGET AUDIENCE
- Pharmaceutical & Drug Development
- Biotechnology & Life Sciences
- Neuroscience & Medical Research
- Healthcare & Clinical Applications
- Academics & Translational Medicine
TECH FEATURES
- Efficient Cholinesterase Inhibition
- Enhanced Aβ Disruption
- Optimized Metal Chelation
- Superior Antioxidant Action
- Advanced Neuroprotection
P27-1321
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com